Antibiotic for E. faecalis in Urine
For uncomplicated urinary tract infections caused by E. faecalis, use nitrofurantoin 100 mg PO every 6 hours for 5 days, or fosfomycin 3 g PO as a single dose. For complicated UTIs or pyelonephritis, ampicillin (high-dose: 18-30 g IV daily in divided doses) or amoxicillin 500 mg PO/IV every 8 hours is the preferred treatment, even when in vitro resistance is reported 1, 2.
Treatment Algorithm Based on Clinical Scenario
Uncomplicated Cystitis (Lower UTI)
- First-line options:
Key point: Nitrofurantoin demonstrates 88% susceptibility against enterococci in clinical studies 3, making it highly effective for lower UTIs. Fosfomycin is FDA-approved specifically for E. faecalis UTIs 1.
Complicated UTI or Pyelonephritis
- Preferred treatment: Ampicillin or amoxicillin at high doses
Critical caveat: High urinary concentrations of ampicillin can overcome in vitro resistance in E. faecalis UTIs. Clinical cure rates of 88.1% and microbiological eradication of 86% have been documented even with ampicillin-resistant strains 2. This is because urinary drug concentrations far exceed serum levels, achieving bactericidal activity despite reported resistance 1, 5.
Vancomycin-Resistant E. faecalis (VRE)
If the isolate is vancomycin-resistant but ampicillin-susceptible:
- First choice: High-dose ampicillin (18-30 g IV daily) or amoxicillin 500 mg every 8 hours 1
- Alternative oral options for uncomplicated cystitis:
If ampicillin-resistant VRE:
- For uncomplicated cystitis: Nitrofurantoin or fosfomycin (as above)
- For complicated/systemic infection: Linezolid 600 mg IV or PO every 12 hours 1 (strong recommendation for enterococcal infections)
Penicillin Allergy
- Preferred: Linezolid 600 mg IV or PO every 12 hours 4
- Alternative: Fluoroquinolones (levofloxacin) if susceptible, though 37% of experts consider this inappropriate due to resistance concerns 4
- Duration: 14 days for most cases 4
Important Clinical Considerations
Do not treat asymptomatic bacteriuria: Differentiate true infection from colonization, especially in catheterized patients. Consider therapeutic abstention in:
- Catheterized patients without systemic symptoms (51% of experts support this) 4
- Polymicrobial cultures suggesting contamination (50% support abstention) 4
- Leukocyturia <10⁴/mL without symptoms (64% support abstention) 4
Catheter management: In catheter-associated UTIs, remove or exchange the catheter when possible. Cure rates are similar whether catheters are exchanged/removed (90.5%) or retained (87.5%), but removal is preferred 2.
Risk factors for treatment failure:
- Immunocompromised status: Lower cure rates (78.1% vs 94.2%) 2
- Underlying urinary tract abnormalities: Lower cure rates (71.4% vs 93.7%) 2
- These patients may require longer treatment courses (21 days vs 14 days) 4
Species-Specific Resistance Patterns
E. faecalis typically shows:
- 88% susceptibility to nitrofurantoin 3
- 72% susceptibility to ampicillin 6
- 51% resistance to fluoroquinolones 6
- Very low vancomycin resistance (1.3%) 1
Avoid fluoroquinolones as empiric therapy due to high resistance rates (>50%) in E. faecalis 6, 7.